These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 2961943

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Importance of atrial natriuretic hormone in an exaggerated natriuresis during acute sodium load in primary aldosteronism.
    Kawabe H, Furukawa T, Saito I, Saruta T.
    Acta Endocrinol (Copenh); 1992 Jan; 126(1):37-43. PubMed ID: 1531279
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Alterations of vasoconstrictor and sodium-regulating hormone systems in vascularly decompensated liver cirrhosis.
    Tulassay T, Tulassay Z, Büki B, Szathmári M, Rascher W.
    Acta Med Hung; 1988 Jan; 45(1):73-81. PubMed ID: 2970621
    [Abstract] [Full Text] [Related]

  • 51. DOCA test for aldosteronism: its usefulness and implications.
    Rodríguez JA, Lopez JM, Biglieri EG.
    Hypertension; 1981 Jan; 3(6 Pt 2):II-102-6. PubMed ID: 7028610
    [Abstract] [Full Text] [Related]

  • 52. Increase of plasma atrial natriuretic peptide levels after sublingual administration of nifedipine in essentially hypertensive patients.
    Rappelli A, Dessì-Fulgheri P, Bandiera F, Di Noto G.
    Int J Cardiol; 1989 Jan; 25 Suppl 1():S25-8. PubMed ID: 2533582
    [Abstract] [Full Text] [Related]

  • 53. Effects of human atrial natriuretic peptide on renal function and vasopressin release.
    Kimura T, Abe K, Shoji M, Tsunoda K, Matsui K, Ota K, Inoue M, Yasujima M, Yoshinaga K.
    Am J Physiol; 1986 May; 250(5 Pt 2):R789-94. PubMed ID: 2939732
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Angiotensin II modulates the intrarenal effects of atrial natriuretic peptide.
    Siragy HM, Lamb NE, Rose CE, Peach MJ, Carey RM.
    Am J Physiol; 1988 Sep; 255(3 Pt 2):F545-51. PubMed ID: 2970801
    [Abstract] [Full Text] [Related]

  • 56. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure].
    Fontana F, Guardigli G, Cappelli M, Bernardi P.
    G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692
    [Abstract] [Full Text] [Related]

  • 57. The effect of atrial natriuretic peptide on plasma renin activity, plasma aldosterone, and urinary dopamine in man.
    Struthers AD, Anderson JV, Payne N, Causon RC, Slater JD, Bloom SR.
    Eur J Clin Pharmacol; 1986 Jul; 31(2):223-6. PubMed ID: 2948826
    [Abstract] [Full Text] [Related]

  • 58. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M, Zosin I, Maser-Gluth C, Hermsen D, Cupisti K, Schott M, Schinner S, Knoefel WT, Scherbaum WA, Willenberg HS.
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [Abstract] [Full Text] [Related]

  • 59. Hormone and blood pressure relationships in primary aldosteronism.
    Nicholls MG, Espiner EA, Ikram H, Maslowski AH, Hamilton EJ, Bones PJ.
    Clin Exp Hypertens A; 1984 Aug; 6(8):1441-58. PubMed ID: 6388912
    [Abstract] [Full Text] [Related]

  • 60. Atrial natriuretic peptide administration to normal and salt depleted rats--effects on digoxin-like immunoreactive factor, aldosterone, ACTH, and renal function.
    Shilo L, Pomeranz A, Rathaus M, Weiss E, Bernheim J, Shenkman L.
    Life Sci; 1988 Aug; 42(19):1855-9. PubMed ID: 2835565
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.